IL-22 is involved in the suppression of colitis through three key biological mechanisms: fortification of epithelial barrier integrity, extracellular matrix secretion, and stimulation of proliferation in gut epithelial stem cells (reviewed by Keir et al. and Arshad et al.)[3, 4]. Here, IL22 is linked to colitis.